NCT00147966View on ClinicalTrials.gov

Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)

PHASE2CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Rheumatoid Arthritis

Interventions

DRUG

rituximab

treatment with rituximab

Trial Locations (1)

92093

UCSD CIT, La Jolla

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

University of California, San Diego

OTHER